Literature DB >> 34497856

Corrigendum to "Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients".

Jue Zhang1, Xin-Bao Li1, Zhong-He Ji1, Ru Ma1, Wen-Pei Bai2, Yan Li1.   

Abstract

[This corrects the article DOI: 10.1155/2021/5533134.].
Copyright © 2021 Jue Zhang et al.

Entities:  

Year:  2021        PMID: 34497856      PMCID: PMC8421173          DOI: 10.1155/2021/9789613

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


In the article titled “Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients” [1], there was an error in Figure 2(b) where mPTS should have been mPFS and mOS should have been mPFS. The corrected Figure 2 is as below.
Figure 1

OS and PFS in the AOC patients. (a) OS of 100 AOC patients. (b) PFS of 79 AOC patients with complete CRS+HIPEC.

  1 in total

1.  Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients.

Authors:  Jue Zhang; Xin-Bao Li; Zhong-He Ji; Ru Ma; Wen-Pei Bai; Yan Li
Journal:  Biomed Res Int       Date:  2021-06-22       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.